ADHD Patients in Andorra Face Elvanse Shortage, Must Travel to Spain
Elvanse 30mg and 50mg doses unavailable locally; patients cross to La Seu d'Urgell.
Key Points
- Elvanse 30mg/50mg out of stock in Andorra, distributed by Farmaco.
- Patients must travel to La Seu d'Urgell, Spain, for supplies.
- 70mg capsules cannot be split for lower doses.
- Shortage disrupts ADHD therapy; no restock date given.
Patients with attention deficit hyperactivity disorder (ADHD) in Andorra who require Elvanse in 30mg or 50mg doses have no local supply and must travel to La Seu d'Urgell to obtain it.
The medication, distributed in the Principat by Farmaco, has been out of stock for several days. Hard capsules mean the 70mg version cannot be split to adjust lower doses, leaving those formats unavailable as alternatives.
Elvanse contains lisdexamfetamine, a central nervous system stimulant that helps manage concentration, impulsivity, and hyperactivity in children and adults with ADHD. Taken once daily, typically in the morning, it provides effects lasting 10 to 14 hours and serves as a key option when other treatments prove ineffective.
The ongoing shortage risks disrupting consistent therapy for affected patients, who now face the inconvenience of crossing into Spain for supplies. No timeline for restocking has been announced.
Original Sources
This article was aggregated from the following Catalan-language sources: